Clinical Trial Update: Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of combining valsartan with amlodipine in hypertensive patients not adequately controlled by ramipril plus fel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• DIOVAN (valsartan)
• NORVASC (amlodipine besylate)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED